HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Immunity Spray Touts US Consumers’ Immunity Health Focus; Category Sales Jump On Amazon

Executive Summary

In a 2,474-person survey conducted for the TheraBreath oral care brand, 40% said they began taking immunity supplements due to the pandemic and 65% named vitamin C as the nutrient most beneficial. Immunity supplement sales on Amazon.com, meanwhile, increased 165% in 2020 to $623m.

You may also be interested in...



As Sustainability Concerns Grow, Plant-Based Gummy Gelling Agents Gaining On Gelatins

Gelatin remains most common gelling agent for gummies, plant-based agents pectin and carrageenan are gaining ground as consumers’ sustainability concerns increase. Dupont Nutrition & Biosciences scientist says pectin and carrageenan have added benefits of higher melting points and lower costs.

P&G Begins US Price Increases In Baby And Feminine Care, Could Expand To Health, Beauty

P&G plans up to double-digit price increases in US baby care, feminine care and adult incontinence and will analyze raw material costs and foreign exchange impacts in its other product categories for other pricing changes.

Same Old Supplement Claim Violations Prompt US Regulators’ Action Under New COVID-19 Authority

FTC files complaint against Quickwork as first action under authority granted in the COVID-19 Consumer Protection Act. The enforcement came after the firm twice ingored warnings to discontinue claims its vitamin D and zinc supplements were equal to or more effective than current vaccines.

Topics

UsernamePublicRestriction

Register

RS151183

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel